Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Planned sale President sold 4,000 shares at an average $12.35 ($49,380)
  2. 4 Planned sale President sold 4,000 shares at an average $12.22 ($48,860)
  3. 4 Planned sale President sold 4,000 shares at an average $11.59 ($46,360)
  4. 4 Planned sale President sold 3,878 shares at an average $11.72 ($45,435)
  5. 4 Planned sale President sold 4,000 shares at an average $12.51 ($50,020)
  6. 4 Planned sale President sold 4,000 shares at an average $12.01 ($48,029)
  7. 4 Planned sale President sold 4,000 shares at an average $11.49 ($45,960)
  8. 4 Planned sale President sold 4,000 shares at an average $11.40 ($45,600)
  9. 4 Planned sale President sold 4,000 shares at an average $11.35 ($45,380)
  10. 4 Planned sale President sold 4,000 shares at an average $10.69 ($42,760)
  11. 4 Planned sale President sold 4,000 shares at an average $10.74 ($42,960)
  12. 4 Planned sale President sold 4,000 shares at an average $10.72 ($42,860)
  13. 4 Planned sale President sold 4,000 shares at an average $10.62 ($42,480)
  14. 4 Planned sale President sold 1,113 shares at an average $10.02 ($11,157)
  15. 4/A Planned sale President sold 833 shares at $11.85 ($9,871)
  16. 4 Planned sale President sold 2,216 shares at an average $10.08 ($22,336)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale President sold 4,000 shares at an average $11.89 ($47,543)
  20. 4 Planned sale President sold 4,000 shares at an average $12.40 ($49,600)

Page 4 of 37 · 739 filings